26 /100
MEDIUM RISK
Score updated May 30, 2026

MPLT — MapLight Therapeutics, Inc. Dilution Risk Tracker

Track MPLT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MPLT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
60
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for MPLT.
🔔 Track MPLT — Get forecast alerts →

💹 Market Data

Market Cap$1.33B
Shares Outstanding42.62M
Float13.31M
Cash$310.11M
Debt$5.59M
Short InterestN/A

🏛 Institutional Holdings

74 institutional holders · 26.19M shares
#1 T. Rowe Price Investment Management, Inc. 5.60M shares
#2 NOVO HOLDINGS A/S 3.69M shares
#3 FCPM III SERVICES B.V. 3.23M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.36M
Days to Cover5.6
% of Float9.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
4 INSIDER TRANSACTION Apr 17, 2026
4 INSIDER TRANSACTION Apr 17, 2026
4 INSIDER TRANSACTION Apr 17, 2026
4 INSIDER TRANSACTION Apr 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track MPLT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MPLT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for MPLT
📊 MPLT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MPLT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.